The Doha Declaration is a WTO declaration that clarifies the scope of TRIPS and, for example, states that TRIPS can and should be interpreted with the aim of “promoting access to medicines for all”. The TRIPS Agreement is an agreement on minimum standards that allows members to guarantee, if they so wish, broader protection of intellectual property. Members are free to determine the appropriate method for implementing the provisions of the Agreement in their own legal and practical order. Council Decision 94/800/EC on the conclusion, on behalf of the EU, of the agreements concluded in the framework of the Uruguay Round multilateral negotiations (1986-1994) As regards the application of the Agreement, the industrialised countries had one year to bring their legislation and practices into conformity with the Convention. TRIPS conditions that impose more standards beyond TRIPS were also discussed.  These free trade agreements contain conditions that limit the ability of governments to create competition for generic drug manufacturers. In particular, the United States has been criticized for promoting protection far beyond the standards prescribed by TRIPS. . . .